the FDA approved Akura Medical's IDE application to initiate the QUADRA-PE study evaluating the Katana thrombectomy system for acute pulmonary embolism (PE). . On October 1, 2024, Surmodics ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback